Clearside Biomedical, Inc. Highlights Leadership in Suprachoroidal Delivery at Asia-Pacific Vitreo-Retina Society Congress
Clearside Biomedical showcased its suprachoroidal delivery technology and pipeline results at the Asia-Pacific Vitreo-Retina Society Congress.Quiver AI SummaryClearside Biomedical, Inc. announced its leadership...
Clearside Biomedical Announces Second Quarter 2022 Financial Results and Provides Corporate Update
- CLS-AX OASIS Phase 1/2a Trial Data from Cohorts 3 & 4 Expected in November 2022 - - Non-Dilutive Financing Agreement with HealthCare Royalty...